Related Experiment Video
Updated: Jun 1, 2025

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Electroresponsive Thiol-Yne Click-Hydrogels for Insulin Smart Delivery: Tackling Sustained Release and Leakage
Helena Muñoz-Galán1,2, Hamidreza Enshaei1,2, João C Silva3,4
1Departament d'Enginyeria Química, Campus Diagonal Besòs (EEBE), Universitat Politècnica de Catalunya Barcelona Tech, Av. Eduard Maristany 10-14, Barcelona 08019, Spain.
Researchers developed an electroactive hydrogel device for precise, controlled insulin delivery. This soft biointerface uses electrochemical stimulation for advanced diabetes treatment, offering potential for bioelectronic applications.
Area of Science:
- Biomaterials Science
- Electrochemistry
- Drug Delivery Systems
Background:
- Diabetes mellitus is a global health concern necessitating improved insulin therapy.
- Current insulin administration methods face challenges in precise dosage and release control.
- Soft biointerfaces offer promising platforms for advanced therapeutic delivery.
Purpose of the Study:
- To develop an electroactive soft biointerface for controlled insulin delivery.
- To utilize a thiol-yne poly(ethylene glycol) (PEG) click-hydrogel system.
- To incorporate poly(3,4-ethylenedioxythiophene) nanoparticles (PEDOT NPs) for electroactivity.
Main Methods:
- Fabrication of a PEG-based click-hydrogel incorporating PEDOT NPs.
- Optimization of PEG precursor and PEDOT NP concentration.
- Density functional theory (DFT) calculations to study PEDOT-PEG interactions.
- Electrochemical stimulation (ES) for controlled insulin release.
- In vitro verification of insulin release using high-performance liquid chromatography (HPLC).
Main Results:
- A functional electroactive hydrogel biointerface was successfully created.
- DFT calculations identified 4-arm PEG precursors as optimal cross-linkers.
- Optimized PEDOT NP concentration ensured gelation and enhanced properties.
- Electrochemical stimulation enabled precise, extended insulin release in vitro.
- The system demonstrated good cytocompatibility and mechanical properties.
Conclusions:
- The developed hydrogel-based device provides a novel method for controlled insulin delivery.
- The incorporation of PEDOT NPs renders the hydrogel electroactive for precise release management.
- This technology holds potential for translation into advanced bioelectronic applications for diabetes management.
More Related Videos
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016